Differentials

Chronic lymphocytic leukemia (CLL)

SIGNS / SYMPTOMS
INVESTIGATIONS
SIGNS / SYMPTOMS

Clinically, CLL and HCL might be indistinguishable.

INVESTIGATIONS

Typically, the immunophenotypic profile for the abnormal B cell in CLL is CD5+ and CD23+ (rarely expressed in HCL), and negative for CD103 (commonly expressed in HCL).[45][50]

CD11c is expressed commonly in B-cell chronic lymphocytic leukemia (B-CLL) and HCL, but the intensity of expression is 30-fold greater in HCL than in B-CLL.[45]

Mantle cell lymphoma

SIGNS / SYMPTOMS
INVESTIGATIONS
SIGNS / SYMPTOMS

Clinically, mantle cell lymphoma and HCL are indistinguishable.

INVESTIGATIONS

Overexpression of cyclin D1 owing to t(11;14) chromosome translocation is a hallmark of mantle cell lymphoma. However, weak expression of cyclin D1 can also be detected in HCL.[41][51][52]​ Typically, the immunophenotypic profile of the abnormal B cell in mantle cell lymphoma is positive for CD5 (rarely expressed in HCL). 

Prolymphocytic leukemia

SIGNS / SYMPTOMS
INVESTIGATIONS
SIGNS / SYMPTOMS

Clinically, prolymphocytic leukemia and HCL are indistinguishable.

INVESTIGATIONS

Marked elevation of WBC count (as opposed to pancytopenia) together with the distinct morphology of prolymphocytes on histologic exam.[45][52]

Splenic marginal zone lymphoma (SMZL)/splenic lymphoma with villous lymphocytes (SLVL)

SIGNS / SYMPTOMS
INVESTIGATIONS
SIGNS / SYMPTOMS

Clinically and morphologically, HCL and SMZL/SLVL might be indistinguishable.

INVESTIGATIONS

SMZL /SLVL cells do not display tartrate-resistant acid phosphatase (TRAP)-positivity and the bone marrow infiltrates are demarcated sharply. The immunophenotypic profile is negative for CD103, CD27, and CD25.[45][52]​ CD11c is expressed commonly in SMZL/SLVL and HCL, but the intensity of expression is 30-fold greater in HCL than SMZL/SLVL.[45]

Annexin A1 (ANXA1) is negative in SMZL/SLVL, whereas it is positive in HCL.

Aplastic anemia

SIGNS / SYMPTOMS
INVESTIGATIONS
SIGNS / SYMPTOMS

Clinically, aplastic anemia and HCL are indistinguishable.

INVESTIGATIONS

Practitioners should beware of erroneous diagnosis of aplastic anemia owing to a dry-tap bone marrow aspirate with hypocellular bone marrow. Immunostaining for B-cell antigens is essential and can prompt specific immunophenotyping for HCL.[41]

Hairy cell leukemia variant (HCL-V; also known as splenic B-cell lymphoma/leukemia with prominent nucleoli [SBLPN])

SIGNS / SYMPTOMS
INVESTIGATIONS
SIGNS / SYMPTOMS

Clinically, HCL-V/SBLPN and HCL are indistinguishable.

INVESTIGATIONS

Absolute monocyte count is usually normal.

HCL-V/SBLPN typically presents with leukocytosis with an average WBC count of approximately 35,000/microliter.

Typical immunophenotype profile is negative for CD25, annexin A1 (ANXA1), and CD123; the abnormal B-cell is TRAP negative.

BRAF V600E mutation is absent.[7][25]

Patients with HCL-V/SBLPN typically do not respond as well to standard HCL treatment.

Use of this content is subject to our disclaimer